Drug-eluting Balloon Catheters Market By Product Type (Paclitaxel Drug-Eluting Balloon Catheters, Sirolimus Drug-Eluting Balloon Catheters) , By Indication (Coronary Intervention, Peripheral Intervention) By End User (Hospitals and ASCs, Catheterization L
Description
Drug-eluting Balloon Catheters Market By Product Type (Paclitaxel Drug-Eluting Balloon Catheters, Sirolimus Drug-Eluting Balloon Catheters) , By Indication (Coronary Intervention, Peripheral Intervention) By End User (Hospitals and ASCs, Catheterization Laboratories, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The drug-eluting balloon catheters market was valued at $0.6 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Drug-eluting balloon catheters are specialized medical devices used in interventional cardiology and vascular procedures. These catheters are coated with medication that is released into the target tissue during the balloon inflation process. This technology aims to prevent restenosis (re-narrowing of blood vessels) after procedures such as angioplasty, where a balloon is used to open up blocked arteries.
The growth of the global drug-eluting balloon catheters market is majorly driven by alarming rise in prevalence of cardiovascular diseases such as coronary artery disease and peripheral artery disease. According to a 2023 study of the World Heart Federation, deaths due to cardiovascular disease increased from 12.1 million in 1990 to 20.5 million in 2021. In addition, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that as individuals age, their bodies undergo natural physiological changes such as arterial stiffness, reduced elasticity of blood vessels, and changes in heart structure and function, which can contribute to conditions like hypertension and heart disease. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, shift toward minimally invasive surgical techniques among healthcare providers and patients leads to higher demand for drug-eluting balloons, thereby augmenting the market growth. Furthermore, increase in investments in healthcare infrastructure and growing spending on advanced medical devices contribute to the market expansion. However, high cost associated with drug-eluting balloon catheters hampers the market growth. In addition, availability of other treatment options, such as drug-eluting stents or traditional surgical procedures, can create competitive pressures and limit the market share for drug-eluting balloon catheters. On the contrary, continuous innovations in catheter design and drug formulation improve the effectiveness and safety profiles of drug-eluting balloon catheters, which are expected to offer lucrative opportunities for the growth of the global market during the forecast period.
The global drug-eluting balloon catheters market size is segmented into product type, indication, end user, and region. By product type, the market is bifurcated into paclitaxel drug-eluting balloon catheters and sirolimus drug-eluting balloon catheters. On the basis of indication, it is classified into coronary intervention and peripheral intervention. Depending on end user, it is fragmented into hospitals and ASCs, catheterization laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product type, the paclitaxel drug-eluting balloon catheters segment is expected to dominate the market from 2024 to 2033.
On the basis of indication, the peripheral intervention segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, hospital segment is likely to grow at a notable pace in the coming years.
Region wise, North America is projected to emerge as the most lucrative market for drug-eluting balloon catheters throughout the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global drug-eluting balloon catheters market include Medtronic, Koninklijke Philips N.V., Becton, Dickinson and Company, Lepu Medical Technology(Beijing)Co.,Ltd., Meril Life Sciences Pvt. Ltd., Biotronik, Zhejiang Barty Medical Technology Co., Ltd., Eurocor Tech GmbH, iVascular, and Concept Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market Segments
By Product Type
Paclitaxel Drug-Eluting Balloon Catheters
Sirolimus Drug-Eluting Balloon Catheters
By Indication
Coronary Intervention
Peripheral Intervention
By End User
Hospitals and ASCs
Catheterization Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Medtronic
Koninklijke Philips N.V.
Becton, Dickinson and Company
Lepu Medical Technology(Beijing)Co.,Ltd.
Meril Life Sciences Pvt. Ltd.
Biotronik
Zhejiang Barty Medical Technology Co., Ltd.
Eurocor Tech GmbH
iVascular
Concept Medical
Table of Contents
220 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product Type
- 4.2. Paclitaxel Drug-Eluting Balloon Catheters
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Sirolimus Drug-Eluting Balloon Catheters
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Indication
- 5.2. Coronary Intervention
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Peripheral Intervention
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals And ASCs
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Catheterization Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: DRUG-ELUTING BALLOON CATHETERS MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product Type
- 7.2.3. Market Size and Forecast, By Indication
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Drug-eluting Balloon Catheters Market
- 7.2.6.1. Market Size and Forecast, By Product Type
- 7.2.6.2. Market Size and Forecast, By Indication
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Drug-eluting Balloon Catheters Market
- 7.2.7.1. Market Size and Forecast, By Product Type
- 7.2.7.2. Market Size and Forecast, By Indication
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Drug-eluting Balloon Catheters Market
- 7.2.8.1. Market Size and Forecast, By Product Type
- 7.2.8.2. Market Size and Forecast, By Indication
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product Type
- 7.3.3. Market Size and Forecast, By Indication
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Drug-eluting Balloon Catheters Market
- 7.3.6.1. Market Size and Forecast, By Product Type
- 7.3.6.2. Market Size and Forecast, By Indication
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Drug-eluting Balloon Catheters Market
- 7.3.7.1. Market Size and Forecast, By Product Type
- 7.3.7.2. Market Size and Forecast, By Indication
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Drug-eluting Balloon Catheters Market
- 7.3.8.1. Market Size and Forecast, By Product Type
- 7.3.8.2. Market Size and Forecast, By Indication
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Drug-eluting Balloon Catheters Market
- 7.3.9.1. Market Size and Forecast, By Product Type
- 7.3.9.2. Market Size and Forecast, By Indication
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Drug-eluting Balloon Catheters Market
- 7.3.10.1. Market Size and Forecast, By Product Type
- 7.3.10.2. Market Size and Forecast, By Indication
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Drug-eluting Balloon Catheters Market
- 7.3.11.1. Market Size and Forecast, By Product Type
- 7.3.11.2. Market Size and Forecast, By Indication
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product Type
- 7.4.3. Market Size and Forecast, By Indication
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Drug-eluting Balloon Catheters Market
- 7.4.6.1. Market Size and Forecast, By Product Type
- 7.4.6.2. Market Size and Forecast, By Indication
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Drug-eluting Balloon Catheters Market
- 7.4.7.1. Market Size and Forecast, By Product Type
- 7.4.7.2. Market Size and Forecast, By Indication
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Drug-eluting Balloon Catheters Market
- 7.4.8.1. Market Size and Forecast, By Product Type
- 7.4.8.2. Market Size and Forecast, By Indication
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Drug-eluting Balloon Catheters Market
- 7.4.9.1. Market Size and Forecast, By Product Type
- 7.4.9.2. Market Size and Forecast, By Indication
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Drug-eluting Balloon Catheters Market
- 7.4.10.1. Market Size and Forecast, By Product Type
- 7.4.10.2. Market Size and Forecast, By Indication
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Drug-eluting Balloon Catheters Market
- 7.4.11.1. Market Size and Forecast, By Product Type
- 7.4.11.2. Market Size and Forecast, By Indication
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product Type
- 7.5.3. Market Size and Forecast, By Indication
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Drug-eluting Balloon Catheters Market
- 7.5.6.1. Market Size and Forecast, By Product Type
- 7.5.6.2. Market Size and Forecast, By Indication
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Drug-eluting Balloon Catheters Market
- 7.5.7.1. Market Size and Forecast, By Product Type
- 7.5.7.2. Market Size and Forecast, By Indication
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Drug-eluting Balloon Catheters Market
- 7.5.8.1. Market Size and Forecast, By Product Type
- 7.5.8.2. Market Size and Forecast, By Indication
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Drug-eluting Balloon Catheters Market
- 7.5.9.1. Market Size and Forecast, By Product Type
- 7.5.9.2. Market Size and Forecast, By Indication
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Medtronic
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Koninklijke Philips N.V.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Becton, Dickinson And Company
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Lepu Medical Technology (Beijing) Co., Ltd.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Meril Life Sciences Pvt. Ltd.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Biotronik
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Zhejiang Barty Medical Technology Co., Ltd.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Eurocor Tech GmbH
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. IVascular
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Concept Medical
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. DRUG-ELUTING BALLOON CATHETERS MARKET FOR PACLITAXEL DRUG-ELUTING BALLOON CATHETERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. DRUG-ELUTING BALLOON CATHETERS MARKET FOR SIROLIMUS DRUG-ELUTING BALLOON CATHETERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 5. DRUG-ELUTING BALLOON CATHETERS MARKET FOR CORONARY INTERVENTION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. DRUG-ELUTING BALLOON CATHETERS MARKET FOR PERIPHERAL INTERVENTION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 8. DRUG-ELUTING BALLOON CATHETERS MARKET FOR HOSPITALS AND ASCS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. DRUG-ELUTING BALLOON CATHETERS MARKET FOR CATHETERIZATION LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. DRUG-ELUTING BALLOON CATHETERS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. DRUG-ELUTING BALLOON CATHETERS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 13. NORTH AMERICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 16. U.S. DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 17. U.S. DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. CANADA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 20. CANADA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. MEXICO DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. GERMANY DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. GERMANY DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 31. GERMANY DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. FRANCE DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. UK DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 36. UK DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 37. UK DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. ITALY DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. SPAIN DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. REST OF EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 45. REST OF EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 48. ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. JAPAN DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 52. JAPAN DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 53. JAPAN DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. INDIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 58. INDIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 59. INDIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. AUSTRALIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 61. AUSTRALIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 62. AUSTRALIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. REST OF ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 67. REST OF ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 70. LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. BRAZIL DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 74. BRAZIL DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. SAUDI ARABIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 77. SAUDI ARABIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 78. SAUDI ARABIA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. SOUTH AFRICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. REST OF LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
- TABLE 83. REST OF LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. MEDTRONIC: KEY EXECUTIVES
- TABLE 86. MEDTRONIC: COMPANY SNAPSHOT
- TABLE 87. MEDTRONIC: OPERATING SEGMENTS
- TABLE 88. MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 89. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
- TABLE 91. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 92. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 93. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 94. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 96. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 97. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 98. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 99. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: KEY EXECUTIVES
- TABLE 101. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT
- TABLE 102. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: OPERATING SEGMENTS
- TABLE 103. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT PORTFOLIO
- TABLE 104. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
- TABLE 106. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
- TABLE 107. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
- TABLE 108. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
- TABLE 109. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. BIOTRONIK: KEY EXECUTIVES
- TABLE 111. BIOTRONIK: COMPANY SNAPSHOT
- TABLE 112. BIOTRONIK: OPERATING SEGMENTS
- TABLE 113. BIOTRONIK: PRODUCT PORTFOLIO
- TABLE 114. BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: KEY EXECUTIVES
- TABLE 116. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
- TABLE 117. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: OPERATING SEGMENTS
- TABLE 118. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
- TABLE 119. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. EUROCOR TECH GMBH: KEY EXECUTIVES
- TABLE 121. EUROCOR TECH GMBH: COMPANY SNAPSHOT
- TABLE 122. EUROCOR TECH GMBH: OPERATING SEGMENTS
- TABLE 123. EUROCOR TECH GMBH: PRODUCT PORTFOLIO
- TABLE 124. EUROCOR TECH GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. IVASCULAR: KEY EXECUTIVES
- TABLE 126. IVASCULAR: COMPANY SNAPSHOT
- TABLE 127. IVASCULAR: OPERATING SEGMENTS
- TABLE 128. IVASCULAR: PRODUCT PORTFOLIO
- TABLE 129. IVASCULAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. CONCEPT MEDICAL: KEY EXECUTIVES
- TABLE 131. CONCEPT MEDICAL: COMPANY SNAPSHOT
- TABLE 132. CONCEPT MEDICAL: OPERATING SEGMENTS
- TABLE 133. CONCEPT MEDICAL: PRODUCT PORTFOLIO
- TABLE 134. CONCEPT MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF DRUG-ELUTING BALLOON CATHETERS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN DRUG-ELUTING BALLOON CATHETERS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDRUG-ELUTING BALLOON CATHETERS MARKET
- FIGURE 10. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET SEGMENTATION, BY PRODUCT TYPE
- FIGURE 11. DRUG-ELUTING BALLOON CATHETERS MARKET FOR PACLITAXEL DRUG-ELUTING BALLOON CATHETERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. DRUG-ELUTING BALLOON CATHETERS MARKET FOR SIROLIMUS DRUG-ELUTING BALLOON CATHETERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET SEGMENTATION, BY INDICATION
- FIGURE 14. DRUG-ELUTING BALLOON CATHETERS MARKET FOR CORONARY INTERVENTION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. DRUG-ELUTING BALLOON CATHETERS MARKET FOR PERIPHERAL INTERVENTION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET SEGMENTATION, BY END USER
- FIGURE 17. DRUG-ELUTING BALLOON CATHETERS MARKET FOR HOSPITALS AND ASCS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. DRUG-ELUTING BALLOON CATHETERS MARKET FOR CATHETERIZATION LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. DRUG-ELUTING BALLOON CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 24. COMPETITIVE DASHBOARD
- FIGURE 25. COMPETITIVE HEATMAP: DRUG-ELUTING BALLOON CATHETERS MARKET
- FIGURE 26. TOP PLAYER POSITIONING, 2023
- FIGURE 27. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. BIOTRONIK: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. BIOTRONIK: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. BIOTRONIK: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. ZHEJIANG BARTY MEDICAL TECHNOLOGY CO., LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. EUROCOR TECH GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. EUROCOR TECH GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. EUROCOR TECH GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. IVASCULAR: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. IVASCULAR: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. IVASCULAR: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. CONCEPT MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. CONCEPT MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. CONCEPT MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
